Deloitte on 'regulatory uncertainty in Europe' - embedding a new modus operandi (?)

In a wonderful example of predicting the present, Deloitte have released a white paper (sign-up required) giving their take on regulatory uncertainty in the European insurance industry, and how the volume of new regulations (and their inability to land on time) is driving emerging best practices in the consideration of regulatory risk at Board level.

New Modus Operandi - alloy wheels optional?

Of course, it is always best to wait for such matters to emerge before proselytising, and the current cup of omni-postponed over-elaborate regulations is running over (Sol II, IFRS 4 Phase II, FATCA, etc), naturally causing difficulties for all those responsible for preparing for them, as well as the execs who take the topics into the boardroom every quarter, only to say "it's been delayed again, can I have more money"...

From my perspective, it was particularly interesting to see that proactivity is recommended regardless of nature/scale/complexity, bearing in mind the first time I spoke to a Board of Directors at a tiny insurer regarding Solvency II preparations was in 2009 - only consultants could comfortably suggest that an new executive-level role is established, and Board agenda time is regularly set aside, only to explain the latest delays in multi-jurisdictional regulations (I certainly know what my old CEO would have said to that!)

That aside, they suggest that two major problems need to be overcome; that few insurers have a single view of regulatory risk; and that regulatory insight is poorly represented in the strategic workings of insurers, both of which are easy to agree with purely on circumstantial evidence.

Whilst this frequently reads like a paper written to justify bringing consultants in to compensate for failing in risk and compliance professionals' armoury, Deloitte make the following noteworthy assertions/recommendations in it;

Trends

• That most insurers prefer to 'wait and see' rather than be 'first mover' when it comes to regulatory preparations - after the Solvency II experience, does that surprise anyone?
• That "...Deloitte's view is that regulation can be regarded as a 'structural' driver of the insurance industry"
• That "...Deloitte's considers a regulatory dividend can and should be sought", which is not necessarily my experience of consultancies when on site, who (presumably for legal reasons) prefer to promote a gold-plated complaince approach to regulation-driven projects.
• Cost of compliance is now materially diluting return on equity in EU insurers
• That Conduct Risk is likely to become high profile across Europe over a longer period of time than its current flavour of the month feel, thanks to IMD2/PRIPS/MIFID
• National regulators are increasingly impeding on day-to-day running - examples given (all of which have a whiff of IMAP requirements about them), include documentation improvements and influencing risk appetite/capital allocation work.

Costs and volume

• Regulation prep cost the European insurance industry €4.2-€4.7bn in 2012 - they go on to expand that to €8.1-€9.2bn over the last 3 years.
• UK industry will be subject to 29 new pieces of legislation of the next 5 years (surprisingly lower than the French at 35, and the Germans at 32!)
• That the "cost of doing nothing" while waiting for regulatory clarity may be significant - as significant as consultancy spend preparing for something which never arrives perhaps?
• That compliance functions are naturally struggling to cope with the current volume of initiatives

Solvency II-specific

• They extrapolate an estimated €550m cost of Solvency II compliance preparations in 2012 into a €1.5bn-€1.8bn 'top 40 insurers' number, and a €2.4-€2.9bn figure for the whole industry - feels a bit light, bearing in mind 'UK plc' must have done the best part of £1bn on Solvency II alone in 2012.
• They quote one strategy director as saying that "Solvency II is killing European M&A..." - p10

Their recommendations (from p19) are too woolly in aggregate to help a normal practitioner - they are probably targeted more towards programme directors and managers - but the recommendation  to establish a Regulatory Assessment and Response Executive with a suitable remit is a smart idea, even if from a practical perspective this might need to either be balled in with the responsibilities of an existing executive, or only be a mid/senior management role, in smaller companies. 

These recommendations also include the marvellous suggestion to "embed a new modus operandi" - an expression normally reserved for profilers of serial killers, and perhaps the hardest sell since Isle of Man beach holidays.

PS I apparently missed the memo where the oft-ridiculed speech of Donald Rumsfeld used to support war against Iraq became de rigeur in risk management/insurance white papers. If there is one "known known" in this world, it is that I will never use that expression on the job!

PwC and CSFI's 2013 Insurance Banana Skins survey - "Conduct Risk" firmly a la mode

Following on from the 2011 version, PwC and the Centre for the Study of Financial Innovation have pumped out another version of their Insurance Banana Skins survey, identifying how well the insurance industry feels it is prepared to handle a list of pre-identified risks. The average response on a scale of 1 to 5 was 2.97, which rather unrevealingly suggests the industry is averagely prepared to manage its collective risk profile.

EU Legislative process - not for vegans

This survey was conducted during March/April 2013, and elicited 662 responses from 54 countries, with two-thirds of respondents coming the insurance industry (the rest consultants/brokers etc). Almost half were European, so no surprises that the risks emerging from the regulatory environment were top of the pops for the second survey in a row. Solvency II gets a particularly flavoursome mention, with reference to its struggles to get through the "Brussels Sausage Machine"...

Bearing in mind the exquisite pressures being applied by the EU machinery to quantify risk, this publication is a welcome return to horizon scanning, qualitative assessment and emerging risk, all of which is handy for the ORSA posse, who according to recent surveys, should be all over this during 2013.

Some very interesting snippets emerge from the report, in particular;

• "Conduct Risk" - if ORSA was the new boy in 2012, then its 2013 counterpart is surely Conduct Risk, which I suspect didn't warrant a category of its own in many risk managers thinking until the return of twin peaks regulation in the UK. Conduct Risk has shot up the charts in its significance for insurers, now sitting 4th (from 18th last year)! Specifically, the suggestion that insurers are now "...looking beyond conduct risk as simply a compliance exercise" makes you wonder what some firms through were acceptable products in the last 10 years!
• "Guaranteed Products" - was not listed last time around, now jumps to number 6
• Actuarial Assumptions (which can easily mask the emergence of a number of the risks listed) unchanged at 12th
• Capital availability down from 2nd last time to 16th this year - interim period been spent squirrelling capital away, or happy that the onerous elements of Solvency II are (thanks to Germany) in the distant future?
• Reputational risk still in mid-table, at 14th

And sectoral/country specific;

• Surprisingly, the Life sector doesn't have actuarial assumptions in its top ten concerns
• Equally surprisingly, the non-life sector doesn't have regulation in its top ten concerns - clearly happy with their proposed Solvency II lot!
• That reputation doesn't feature in reinsurer's top ten - with customers likely to be eager yet more discerning  under Solvency II, one would think this is an area for enhancement in order to stand out from the similarly-rated crowd
• The quality of risk management appears to have spiked as a concern largely due to the emergence of emerging market firms into the space playing catch-up (on paper at least), as well as concerns that some firms are playing at risk management without making necessary adaptations to the prevailing risk culture.

ABI and PRA on 'Meeting the Challenges of a Changing World' - Solvency II in particular...

Low Yield issue - not just for insurers

While I disposed of my son for the summer last week for an extensive potty training course in Bordeaux (PS you might want to avoid the 2013 whites!), the ABI gathered the great and good for their biennial conference, themed Meeting the Challenges of a Changing World.

A corresponding publication from the ABI which the event hung its hat off to a certain extent is particularly useful for anyone in the emerging risk/ORSA/reverse stress testing space, touching on 7 specific 'challenge' themes, which are themself further broken into sub-categories. With the ABI providing a mouthpiece for the interests of the UK insurance industry (and being currently Chaired by an avid opponent of Solvency II), it was worth picking up on this document's take on Solvency II, specifically;

• That it could be a future constraint on the nascent equity release market
• Its well documented "...potential effects on infrastructure financing"
• That British insurers should "...[continue] being proactive and engaged in trying to shape vital regulation such as Solvency II rather than simply criticising it from the sidelines". Not sure if the implication is that the UK is drifting from the box-seat in this regard, but certainly in the context of the next decade, a slated in/out referendum on EU membership may make proactivity on Solvency II a moot point!

The regulatory meat in this lobbyist event sandwich came from a keynote speech by the PRA's Andrew Bailey which, in the process of publicly revealing a few nuggets of truth, still left me safe in the knowledge that insurance is still the banking industry's boring cousin - that he needed to "...make clear at outset that insurance supervision matters as much as banking supervision" and stress that "...insurance supervision is a skill on its own" while supporting most prevailing regulatory techniques with the prefix 'what we learned from Banking is...' tells its own story.

That aside, the following comments are worthy of highlighting;

• The PRA's current trend of using "business model analysis" in their supervisory work - surprised that this was not already par for the course frankly (what else other than the types of analyses referenced at the bottom of p4 would you be doing?), but one would expect that the advent of ORSA will enhance everyone's activity in this field soon.
• Taking that into account, it is "...logical for us to make early adjustments to our existing regime to incorporate the ORSA under ICAS+"
• The suggestion that management "...take responsibility for understanding and mitigating the risks in their business" - 'managing', rather than 'mitigating' surely, we'll tolerate anything within appetite!
• That the truly woeful "Solvency II/Crossrail" costing analogy used by Mr Bailey to a parliamentary select committee was the PRA "...making a point on behalf of firms".
• That "PRA have not withdrawn from involvement in Solvency II, far from it", though recognises that the result around the classic matching adjustment is not what UK plc would wish for - goes on to comment that we "...still have a good way to go to make the Solvency II regime manageable in its use and implementation"
• That, as far as Sol II's legislative progress is concerned, negotiations "...continue over summer, with a conclusion expected in the autumn", and that the official implementation date discussed recently on this blog is "clearly unrealistic".

In a week where a wall of silence has descended upon the co-legislators and the Commission, it is reassuring to see at least one NSA body with a solid-ish implementation plan, regardless of the immediate lack of things to implement - however judging by the words captured by Gideon of Dr. Wiedner, the lightly briefed (and from what I could read, lightly fed) replacement of Karel van Hulle, I suspect that Solvency II on the whole remains "Klaus but no cigar"...

AKG - Solvency II perspectives from the financial advisory industry

In the absence of materials pointed towards the sector, AKG have released a Solvency II guide for financial advisers (sign-up required, but worth it), which provides a refreshing angle change from the usual bureaucrats vs lobbyists vs politicians chatter flooding the trade presses.

Solvency II and RDR -
"mess with me, you mess
with my whole family"

While Solvency II was clearly De Vito to RDR's Schwarzenegger over the last year and a half for the financial advisory industry (indeed all bar one of those surveyed by AKG's pollsters had been concentrating "exclusively" on RDR), there was at least some familiarity with the impact on product availability from the current impasse - Protection and Annuity rates, With Profits availability and Guarantee costs are all on the industry's radar.

While there was a couple of faux pas in the document (the official timeline is certainly not "established and managed by EIOPA", and as the world and her husband will tell you, the ORSA is not an annual report!), the document helps understand the concerns and needs of the distribution world at this uncertain time. I picked out the following;

• That CROs will be more concerned about risks posed by external distributors and advisors in future
• That advisers will likewise need assurance on product supplier risks, and that provider and product ratings from external sources "...will be crucial components in gaining this reassurance"
• That the alignment of capital and risk "...will undoubtedly drive capital light products in future"
• That the mainstream press hasn't yet "gone big" on Solvency II, but that advisers may get caught out when they do
• That the advisory industry wants "...a guide [to Solvency II] to explain in an easy-to-understand, jargon-free manner" - over to you FCA!
• There are concerns around the quantum and familiarity of products/providers once Solvency II goes live and we see new market entrants/consolidation

They conclude that "advisers should not panic about Solvency II and its implications". That has a whiff of Chamberlain about it to say the least, but the "panic" would be about convincing punters to pay more for guarantees or share the risks in insurance products in the near future, as opposed to the solvency adequacy of the providers themselves.

KPMG - Solvency II paper, "Beyond compliance towards optimisation"

Another titbit from the Big 4, this time covering the benefits that are available off the back off the legislative delays, specifically around optimising the Finance and Risk functions. If you are one of the Tier 1 companies, this comes across as a bit of a "Where's Wally" paper (or 'Waldo' for my American pals!), as it borrows of their extensive 'experience' on site with clients over the last few years. Despite that extensive experience, this is pretty light at a fistful of pages.

I would struggle to distinguish between 'capital minimisation' and 'capital optimisation', which they start off with, but they go on to describe a world of risk and finance "centres of excellence, which utilise the good work currently being done on the data warehousing front by Data teams to populate the various regulatory reporting requirements as well as management information needs, and that all sounds plausible.

The Risk section is naturally a little flannel-y, but suggests the best functions will be able to predict cash flows better, ultimately improving risk, capital and business planning and as a by-product, RAROC comprehension and enhancement.

Not a lot else, but some ideas around communicating future value of today's expenditure at the very least.

Leadership, psychos and moon faces

On the corporate governance front, please be on the look out for any psychopaths or wide faced execs who may be the causes of your strategic undoing...

FT report on listed insurer's capital trends

Just in case anyone missed out on Monday, the FT provided a quality summary on perceived advance capital planning by UK and EU insurers ahead of Solvency II. I say quality despite the couched terminology (SCR referred to as the "softer capital requirement"!)

The suggested SCR coverage targets referenced are interesting (125-150% in the UK, and as much as 170% in continental Europe) – I have heard generalisations on target SCR surplus before (in the context of economic capital targets), but the guy from JP Morgan obviously thinks he’s onto something.

I had a quick look, and thought Generali may struggle on the European side (they had 168% as their Economic Solvency Coverage on p23), but everyone else was well covered.

The schematic also highlights the increase in surplus capital pre and post-credit crunch.

Swiss Re World Insurance in 2010 sigma study - no love for Solvency II

Swiss Re have pushed out their World Insurance trends research - expect to see it cited from pillar to post, as it is an exceptional body of work, with a whole host of uses (benchmarking, strategic planning and risk monetising as a minimum).

I have just kept an eye on the Solvency II aspects - references were as follows;

• Higher capital requirements for long-tail business and "overly stringent" capital requirements noted as a challenge which could undermine profitability
• "Onerous" capital requirements deriving from Solvency II could harm policyholders and economic growth
• Life companies will be "forced to shift assets into less risk asset classes"
• "Stricter solvency regulation (Solvency II) and higher capital requirements will be implemented by ratings agencies going forward"
• "Positive step" of Solvency II nullified somewhat by the tightening of "key parameters" since the credit crisis, leading to (potentially) higher capital requirements for "the most important life insurance products"

All in all, pretty negative as far as the predicted impact of Solvency II in its current form on the future of the insurance industry. Fair?

Accenture Global Risk Management Study 2011 - talking points

A rather lavish piece of research from Accenture on developments in using risk as a source of competitive advantage was pushed out yesterday - All industry version here, with Insurance-specific report here.

Solvency II doesn't really feature in the global study (which covered just under 400 risk execs), but some aggregate trends are worth noting (observations against their 2009 survey);

• Increased likelihood of execuitve-level oversight of the risk function
• Increased concern about coverage of the spectrum of risk (types and severity coverage)
• Almost half of respondents had "reducing costs" as one of their main challenges in next 2 years
• Vast majority have either a CRO or an executive with Risk responsibility
• Majority of medium term spend seems to be focused towards data and technological improvements
• 40% have responded that regulatory risk will be "significantly increasing" in next 2 years
• Integration of risk measure capture and use across busienss areas particularly poor (most categories of risk were under 50% rated as "highly integrated across business units".
• Some lareg gaps between the importance of the risk function's objectives against their achievement (worryingly large on the matter of ensuring sustainability of future profitability)

For Insurance-specific, I noted the following (around 50-odd companies by my count);

• 80% of respondentshave ERM program in place or in planning
• Top risk executive reports to CEO in almost 90% of respondents (a truly horrifying statistic, and the highest of all industries) 
• 81% of Life company respondents felt regulatory pressure is creating an increasing gap to achieving compliance
• 54% have a CRO who owns responsibility for Risk in their organisations (surely a massive no-no under Solvency II)
• Integration of Finance and Risk and improving reporting capabilities on risk-adjusted performance management are the highest Life company priorities for improving capabilities.
• To achieve "Risk Mastery", a rather anodyne list of enhancements are depicted - invest in analytic tools, integrate risk and finance, improve approaches to fraud and financial crime and leverage compliance initiatives (such as Solvency II I guess, though I wouldn't call it a compliance initiative!)

They create a sub-category of "Risk Masters", whose risk management capabilities are assumed to be superior to the crowd - these are the component parts of "risk mastery";

1. Creation of shareholder value from Risk Management
2. Risk Management involved in key decision making process
3. Improved sophiostication of measurement, monitoring and analysis
4. Going beyond a compliance mindset
5. Integration of risk management capabilities across business units and structures
6. Establishment of a "c-suite" role for Risk
7. Infusion of "|risk awareness" across the organisational culture
8. Investment in continuous improvement

Risk masters (around 40 of the respondents qualified) either have or are in the process of establishing ERM programs, and tend to use their Risk function outputs to achieve quantifiable business objectives considerably more than the pack. They also had significantly higher scores for having "highly integrated" risk measure capture and usage across business units (including using these measures in their decision making process), and the majority participate in most areas of the strategic decision making process.

Interestingly, almost 90% of Risk Masters said that they are active in influencing risk regulation in their relevant industry - Solvency II anyone?

ABI Conference - Single European Regulator?

EIOPA's Chief Exec kindly planted the seed of the single EU regulator at the ABI today - bearing in mind how the EU functions are struggling with consensus for Omnibus II right now, this is one matter best pushed to the back of the cabinet!